H.R. 7528 — Introduced in House

I 119th CONGRESS 2d Session H. R. 7528 IN THE HOUSE OF REPRESENTATIVES February 12, 2026Mr. Carter of Georgia introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend section 503B of the Federal Food, Drug, and Cosmetic Act to enhance the ability of outsourcing facilities to mitigate drug shortages by allowing a short-term period to continue supplying the market after a drug is in shortage. 1. Short title This Act may be cited as the Growing America’s Pharmaceutical Supply Act or the GAP Supply Act. 2. Providing for a tail period for outsourcing facilities to compound and distribute drugs in shortage Section 503B of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353b) is amended— (1) in subsection (a)(2)(A)(ii), by striking at the time and inserting within 180 calendar days; and (2) in subsection (d)(2)(A), by striking at the time and inserting within 180 calendar days.